Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Part of paid clinical trials in West Lafayette, Indiana.
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Study ID
- NCT07828860
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hidradenitis Suppurativa (HS)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Soquelitinib — DRUGTablets
Study Details
Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa
Key Dates
- First listed
- Sep 18, 2026
- Start date
- Sep 30, 2026
- Status verified
- Sep 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 25 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Other: Single-ArmParticipants receive open-label single arm of active tablets orally twice daily for 84 days.
Primary Outcome Measure
Incidence of adverse events, changes in laboratory values, vital signs, and ECGs [ Time Frame: up to 30 days after last intervention administration ]
Central Contacts
- Corvus Trials Inquiry650-900-4514
Locations (11)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Clinical Site 9 | West Lafayette | Indiana | 47906 | - |
| Clinical Site 1 | Bowling Green | Kentucky | 42104 | - |
| Clinical Site 2 | Owensboro | Kentucky | 42303 | - |
| Clinical Site 3 | Boston | Massachusetts | 02215 | - |
| Clinical Site 5 | New York | New York | 10023 | - |
| Clinical Site 4 | The Bronx | New York | 10455 | - |
| Clinical Site 11 | Fargo | North Dakota | 58103 | - |
| Clinical Site 10 | Mayfield Heights | Ohio | 44124 | - |
| Clinical Site 6 | Camp Hill | Pennsylvania | 17011 | - |
| Clinical Site 8 | Philadelphia | Pennsylvania | 19103 | - |
| Clinical Site 7 | Nashville | Tennessee | 37211 | - |
Find similar trials in West Lafayette, IN
Related Studies
- Rollover Study for Participants Previously Enrolled in Clinical Trials of PovorcitinibPHASE3 · Recruiting · Incyte Corporation · Birmingham, Alabama
- A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) TherapeuticRecruiting · Sonoma Biotherapeutics, Inc. · San Francisco, California
- Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaPHASE2 · Recruiting · Incyte Corporation · Birmingham, Alabama
- The Safety and Efficacy of Roflumilast Foam in HSPHASE2 · Recruiting · Beth Israel Deaconess Medical Center · Boston, Massachusetts